GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » PB Ratio

Creo Medical Group (LSE:CREO) PB Ratio : 0.75 (As of Apr. 11, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-11), Creo Medical Group's share price is £0.0985. Creo Medical Group's Book Value per Share for the quarter that ended in Jun. 2024 was £0.13. Hence, Creo Medical Group's PB Ratio of today is 0.75.

The historical rank and industry rank for Creo Medical Group's PB Ratio or its related term are showing as below:

LSE:CREO' s PB Ratio Range Over the Past 10 Years
Min: 0.61   Med: 1.85   Max: 5.62
Current: 0.75

During the past 9 years, Creo Medical Group's highest PB Ratio was 5.62. The lowest was 0.61. And the median was 1.85.

LSE:CREO's PB Ratio is ranked better than
84.68% of 790 companies
in the Medical Devices & Instruments industry
Industry Median: 2 vs LSE:CREO: 0.75

During the past 12 months, Creo Medical Group's average Book Value Per Share Growth Rate was -33.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -24.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -6.50% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Creo Medical Group was 289.10% per year. The lowest was -24.40% per year. And the median was 73.45% per year.

Back to Basics: PB Ratio


Creo Medical Group PB Ratio Historical Data

The historical data trend for Creo Medical Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group PB Ratio Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 3.29 4.87 3.68 0.93 2.77

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.73 0.93 1.78 2.77 2.46

Competitive Comparison of Creo Medical Group's PB Ratio

For the Medical Devices subindustry, Creo Medical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's PB Ratio falls into.


;
;

Creo Medical Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Creo Medical Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=0.0985/0.131
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Creo Medical Group  (LSE:CREO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Creo Medical Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group Business Description

Traded in Other Exchanges
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.

Creo Medical Group Headlines

No Headlines